![Kenneth P. H. Pritzker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth P. H. Pritzker
Oprichter bij Rna Diagnostics, Inc.
Profiel
Kenneth P.
H.
Pritzker is the founder and director of RNA Diagnostics, Inc. which is founded in 2010.
He also held a director position at CareRx Corp.
in 2009.
Actieve functies van Kenneth P. H. Pritzker
Bedrijven | Functie | Begin |
---|---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Oprichter | 01-01-2010 |
Eerdere bekende functies van Kenneth P. H. Pritzker
Bedrijven | Functie | Einde |
---|---|---|
CARERX CORPORATION | Directeur/Bestuurslid | 25-06-2009 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARERX CORPORATION | Health Services |
Bedrijven in privébezit | 1 |
---|---|
Rna Diagnostics, Inc.
![]() Rna Diagnostics, Inc. Medical SpecialtiesHealth Technology Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada. | Health Technology |